Contents

Current Cancer Drug Targets, Volume 14 - Number 9

Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer

, 14(9): 775 - 793

Deepa Subramaniam, Aiwu R. He, Jimmy Hwang, John Deeken, Michael Pishvaian, Marion L. Hartley and John L. Marshall


DOI: 10.2174/1568009614666141111104643





Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex

, 14(9): 794 - 816

Roman Mezencev


DOI: 10.2174/1568009614666141128105146





LAT1 Targeted Delivery of Methionine Based Imaging Probe Derived from M(III) Metal Ions for Early Diagnosis of Proliferating Tumours using Molecular Imaging Modalities

, 14(9): 817 - 831

Puja P. Hazari, Surbhi Prakash, Virendra K. Meena, Ambika Jaswal, Harleen Khurana, Surabhi K. Mishra, Hemanth kumar Somu Bhonsle, Lokendra Singh and Anil K. Mishra


DOI: 10.2174/1568009614666141020102337





Looking out for Cancer Stem Cells’ Properties: The Value-Driving Role of CD44 for Personalized Medicines

, 14(9): 832 - 849

Sara Horta, Ana L. Agostinho, Rita Mateus, Lucilia Pereira, Carolina Pereira, Liliana Capinha, Slavomira Doktorovova, Alexandra Brito and Mafalda Videira


DOI: 10.2174/1568009614666141111154713





TXNL1 Induces Apoptosis in Cisplatin Resistant Human Gastric Cancer Cell Lines

, 14(9): 850 - 859

Pan Ni, Wenxia Xu, Yajie Zhang, Qi Chen, Aiping Li, Shouyu Wang, Shan Xu and Jianwei Zhou


DOI: 10.2174/1568009614666141028094612





Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo

, 14(9): 860 - 871

Rui Zhou, Zongliang Lu, Kai Liu, Jing Guo, Jie Liu, Yong Zhou, Jian Yang, Mantian Mi and Hongxia Xu


DOI: 10.2174/1568009614666141128104642





Acknowledgements to Reviewers:

, 14(9): 872 - 873


DOI: 10.2174/156800961409150111211723




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science